Chemical Components and Hepatoprotective Mechanism of Xwak Granule in Mice Treated with Acute Alcohol
Related Experiment Video
Updated: Dec 5, 2025
Li Chen1,2, Liu Liu1, Rahima Abdulla1
1Key Laboratory of Chemistry of Plant Resources in Arid Regions, State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.
Objective:
To evaluate the hepatoprotective mechanism of Xwak granule (Xwak) in treatment of mice with alcoholic liver injury via activating ERK/NF-κB and Nrf/HO-1 signaling pathways.
Methods:
The chemical composition of Xwak was tested by liquid chromatography coupled with mass spectrometry (LC-MS). Herein, 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging assay and 2,2-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid (ABTS) radical tests were performed in vitro. The hepatoprotective effect of Xwak was assessed at different concentrations (1.5, 3, and 6 g/kg) in a mouse model of alcoholic liver injury.
Results:
Totally, 48 compounds, including 16 flavonoids, 8 tannins, 9 chlorogenic acids, and 15 other compounds, were identified from Xwak. Xwak showed to have a satisfactory antioxidant activity in vitro. In a group of Xwak-treated mice, the serum levels of alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) were decreased compared with a group of the mouse model of alcoholic liver injury. In addition, the levels of antioxidant enzymes, such as glutathione peroxidase (GSH-PX), total superoxide dismutase (T-SOD), and catalase (CAT), were noticeably increased and the levels of malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β), and interleukin-6 (IL-6) were markedly reduced in the liver of mice. The state of oxidative stress in the mouse model of alcoholic liver injury was improved after treatment with Xwak. The improvement of inflammation-mediated disruption may conducive to the Xwak activity in the control of liver injury. The signals of p-ERK1/2, p-NF-κB, COX-2, iNOS, CYP2E1, Nrf, and HO-1 were significantly induced in the liver of mice after treatment with Xwak.
Conclusions:
The abovementioned findings indicated that the hepatoprotective mechanism of Xwak could be achieved by activating ERK/NF-κB and Nrf/HO-1 signaling pathways to alleviate oxidative stress and inflammatory.
Insights
Xwak granule protects the liver from alcohol injury by reducing oxidative stress and inflammation. It activates ERK/NF-κB and Nrf/HO-1 pathways, improving liver function in mice.
Area of Science:
- Pharmacology
- Hepatology
- Traditional Chinese Medicine
Background:
- Alcoholic liver injury (ALI) is a major health concern globally.
- Oxidative stress and inflammation are key mechanisms in ALI pathogenesis.
- Xwak granule is a traditional Chinese medicine preparation with potential therapeutic benefits.
Purpose of the Study:
- To elucidate the hepatoprotective mechanism of Xwak granule in a mouse model of ALI.
- To investigate the role of ERK/NF-κB and Nrf/HO-1 signaling pathways in Xwak's protective effects.
Main Methods:
- Chemical composition of Xwak analyzed using LC-MS.
- In vitro antioxidant activity assessed via DPPH and ABTS assays.
- Hepatoprotective effects evaluated in a mouse model of ALI at varying Xwak concentrations (1.5, 3, 6 g/kg).
Main Results:
- Xwak demonstrated significant in vitro antioxidant activity.
- Xwak treatment reduced serum ALT, AST, and ALP levels in ALI mice.
- Xwak increased antioxidant enzymes (GSH-PX, T-SOD, CAT) and decreased MDA, TNF-α, TGF-β, and IL-6 levels.
- Xwak activated ERK/NF-κB and Nrf/HO-1 signaling pathways, reducing oxidative stress and inflammation.
Conclusions:
- Xwak exhibits significant hepatoprotective effects against alcoholic liver injury in mice.
- The mechanism involves the activation of ERK/NF-κB and Nrf/HO-1 signaling pathways.
- Xwak alleviates liver injury by mitigating oxidative stress and inflammation.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
